JP2019014666A5 - - Google Patents

Download PDF

Info

Publication number
JP2019014666A5
JP2019014666A5 JP2017131890A JP2017131890A JP2019014666A5 JP 2019014666 A5 JP2019014666 A5 JP 2019014666A5 JP 2017131890 A JP2017131890 A JP 2017131890A JP 2017131890 A JP2017131890 A JP 2017131890A JP 2019014666 A5 JP2019014666 A5 JP 2019014666A5
Authority
JP
Japan
Prior art keywords
orally disintegrating
disintegrating tablet
drug
tablet according
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017131890A
Other languages
English (en)
Japanese (ja)
Other versions
JP7182356B2 (ja
JP2019014666A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2017131890A priority Critical patent/JP7182356B2/ja
Priority claimed from JP2017131890A external-priority patent/JP7182356B2/ja
Publication of JP2019014666A publication Critical patent/JP2019014666A/ja
Publication of JP2019014666A5 publication Critical patent/JP2019014666A5/ja
Application granted granted Critical
Publication of JP7182356B2 publication Critical patent/JP7182356B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017131890A 2017-07-05 2017-07-05 口腔内崩壊錠及びその製造方法 Active JP7182356B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2017131890A JP7182356B2 (ja) 2017-07-05 2017-07-05 口腔内崩壊錠及びその製造方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2017131890A JP7182356B2 (ja) 2017-07-05 2017-07-05 口腔内崩壊錠及びその製造方法

Publications (3)

Publication Number Publication Date
JP2019014666A JP2019014666A (ja) 2019-01-31
JP2019014666A5 true JP2019014666A5 (enExample) 2020-08-13
JP7182356B2 JP7182356B2 (ja) 2022-12-02

Family

ID=65356363

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017131890A Active JP7182356B2 (ja) 2017-07-05 2017-07-05 口腔内崩壊錠及びその製造方法

Country Status (1)

Country Link
JP (1) JP7182356B2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7250305B2 (ja) * 2018-10-02 2023-04-03 共和薬品工業株式会社 メマンチン又はその薬物学的に許容される塩を含む医薬組成物及びその製造方法
JP7036856B2 (ja) * 2019-03-28 2022-03-15 日本ケミファ株式会社 口腔内崩壊錠
JP7744908B2 (ja) * 2020-07-27 2025-09-26 第一三共株式会社 ミロガバリンベシル酸塩を含有する口腔内崩壊錠

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008081448A (ja) * 2006-09-28 2008-04-10 Kowa Pharmaceutical Co Ltd 酒石酸ゾルピデムの苦味マスキング速放性粒子
JP5405752B2 (ja) * 2007-01-31 2014-02-05 大日本住友製薬株式会社 被覆された薬物含有粒子および該粒子を含む固形製剤
KR20090119993A (ko) * 2007-03-13 2009-11-23 다이닛본 스미토모 세이야꾸 가부시끼가이샤 구강내 붕괴정
JP5933268B2 (ja) * 2009-12-28 2016-06-08 ニプロ株式会社 品質が向上した経口剤
JP4803686B2 (ja) * 2010-08-31 2011-10-26 協和発酵キリン株式会社 苦味を呈する薬物を含有する顆粒および口腔内崩壊錠
EP2719377B1 (en) * 2011-06-10 2018-04-18 Nipro Corporation Method for producing orodispersible tablets
IN2014MN02029A (enExample) * 2012-04-24 2015-08-14 Daiichi Sankyo Companyltd
JP2017048174A (ja) * 2015-09-01 2017-03-09 大原薬品工業株式会社 化学的に安定な原薬含有被覆粒子を含む口腔内崩壊錠剤
JP6093829B1 (ja) * 2015-10-02 2017-03-08 バイエル薬品株式会社 ランタン化合物を含む医薬組成物

Similar Documents

Publication Publication Date Title
NZ600640A (en) Abuse-resistant formulations
UY33062A (es) Comprimidos y composiciones farmacéuticas comprimibles recubiertos y métodos de fabricación
MX347753B (es) Formulaciones resistentes al abuso.
PH12015502134B1 (en) Mosapride sustained-release formulation providing pharmacological and clinical effects with once-daily administration
FI3182975T3 (fi) Rukaparibin suuren annosvahvuuden tabletteja
FI3684333T3 (fi) Suuren annostuksen valbenatsiiniformulaatio ja siihen liittyviä koostumuksia, menetelmiä ja pakkauksia
JP2015511635A5 (enExample)
PH12019502782A1 (en) Fixed dose formulations
WO2014144130A3 (en) Pharmaceutical composition comprising an ampk activator and a serotonergic agent and methods of use thereof
CO6300931A2 (es) Composiciones farmaceuticas que comprenden particulas de liberacion controlada con un nucleo que comprende farmacos levemente basicos
JP2013544850A5 (enExample)
JP2016540021A5 (enExample)
JP2017531033A5 (enExample)
JP2014218522A5 (enExample)
JP2011063627A5 (enExample)
MX2016014771A (es) Forma de dosificacion oralmente desintegrante para administracion de avanafil, y metodos de fabricacion y uso asociados.
JP2014221827A5 (enExample)
MX2019015733A (es) Formulacion de melatonina oralmente disoluble con agente acidificante que produce melatonina soluble en saliva.
JP2014024874A5 (enExample)
CO6731095A2 (es) Composición farmacéutica de administración oral para el tratamiento del síndrome de intestino irritable digestivas a base de un modificador de la motilidad intestinal, un agente que previene la retención de gases y enzimas digestivas y proceso para su preparación
MX339136B (es) Composicion de liberacion pulsatil de sildenafil y proceso para prepararla.
JP2019517536A5 (enExample)
JP2015129124A5 (enExample)
JP2009091362A5 (enExample)
JP2009505991A5 (enExample)